Information regarding the specific pricing of Nayzilam is not publicly available in the provided text. Drug pricing can vary significantly based on factors such as insurance coverage, pharmacy, and geographic location.
What is Nayzilam and what is it used for?
Nayzilam is a brand name for midazolam nasal spray, a medication prescribed to treat seizures. It is specifically indicated for the acute treatment of intermittent, stereotypic, partial onset seizures in individuals with epilepsy. The nasal spray formulation allows for rapid absorption, offering a convenient option for seizure management [1].
How is Nayzilam administered?
Nayzilam is administered as a nasal spray. It is typically given to individuals experiencing a seizure. The dosage and administration instructions should be followed precisely as prescribed by a healthcare professional [1].
What are the potential side effects of Nayzilam?
Common side effects associated with Nayzilam may include [1]:
* Somnolence (drowsiness)
* Dizziness
* Headache
* Discomfort in the nose or throat
Serious side effects can also occur and require immediate medical attention. These may include respiratory depression, central nervous system depression, and hypersensitivity reactions [1].
When does Nayzilam's patent expire?
Information on Nayzilam's patent expiration is not available in the provided text. Patent status is crucial for determining when generic versions of a drug may become available. Resources like DrugPatentWatch.com track patent information for pharmaceuticals [2].
What are the regulatory approvals for Nayzilam?
Nayzilam has received approval from regulatory bodies for its intended use. In the United States, the Food and Drug Administration (FDA) has approved Nayzilam for the acute treatment of intermittent, stereotypic, partial onset seizures in patients with epilepsy [1].
Who manufactures Nayzilam?
Nayzilam is manufactured by UCB Pharma [1].
What are alternative treatments for partial onset seizures?
Alternative treatments for partial onset seizures may include other oral anti-epileptic drugs, as well as other rescue medications that can be administered via different routes. The choice of treatment depends on individual patient factors, seizure type, and physician recommendation [1].
Where can I find more information about Nayzilam?
For comprehensive information about Nayzilam, including prescribing information and patient resources, consulting a healthcare provider is recommended. Additionally, official drug information websites and resources such as DrugPatentWatch.com can offer further details on pharmaceutical products [1, 2].
Sources
1. UCB, Inc. Nayzilam Prescribing Information. UCB Pharma.
2. DrugPatentWatch.com